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Abstract
Human cytomegalovirus (HCMV) has been shown to induce increased lipogenesis in infected cells, and this is believed to be
required for proper virion envelopment. We show here that this increase is a consequence of the virus-induced
redistribution of the host protein viperin to mitochondria and its capacity to interact with and block the function of the
mitochondrial trifunctional protein (TFP), the enzyme that mediates fatty acid-b-oxidation. The resulting decrease in cellular
ATP levels activates the enzyme AMP-activated protein kinase (AMPK), which induces expression of the glucose transporter
GLUT4, resulting in increased glucose import and translocation to the nucleus of the glucose-regulated transcription factor
ChREBP. This induces increased transcription of genes encoding lipogenic enzymes, increased lipid synthesis and lipid
droplet accumulation, and generation of the viral envelope. Viperin-dependent lipogenesis is required for optimal
production of infectious virus. We show that all of these metabolic outcomes can be replicated by direct targeting of viperin
to mitochondria in the absence of HCMV infection, and that the motif responsible for Fe-S cluster binding by viperin is
essential. The data indicate that viperin is the major effector underlying the ability of HCMV to regulate cellular lipid
metabolism.
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Introduction
Human cytomegalovirus (HCMV) is associated with acute and
chronic disease in both healthy and immunocompromised
populations [1,2,3]. A characteristic of HCMV is that it modulates
the metabolism of an infected cell in ways that favor viral
replication [4,5,6]. HCMV infection has been shown to induce the
expression of glucose transporter 4 (GLUT4) and its translocation
to the cell surface, which results in an increase in cytoplasmic
glucose that is used for de novo fatty acid biosynthesis [4,5,6,7,8].
The increase in GLUT4 expression during HCMV infection has
been shown to result from activation of AMP-activated protein
kinase (AMPK) [9]. The increase in fatty acid biosynthesis leads to
the accumulation of lipids that are used for formation of the viral
envelope [10,11]. Consistent with this, pharmacological inhibition
or siRNA-mediated knockdown of fatty acid synthetic enzymes
reduces HCMV replication [5,10].
Two major classes of transcription factors regulate de novo fatty
acid synthesis by inducing the expression of lipogenic enzymes.
These are sterol regulatory element binding proteins (SREBPs)
and carbohydrate responsive element binding protein (ChREBP),
which are insulin- and glucose-responsive transcription factors,
respectively [12,13,14,15,16,17]. In cells with sufficient sterol
levels, SREBPs remain in the endoplasmic reticulum (ER). When
sterol levels are depleted, the insulin-stimulated SREBPs are
transported to the Golgi where they are cleaved to a mature form
and translocated into the nucleus. The cleaved forms of SREBPs
up-regulate the expression of lipogenic genes [13,14,15]. ChREBP
is also an important transcriptional regulator for de novo lipogenesis.
Glucose activates ChREBP by regulating its redistribution from
the cytosol to the nucleus by a phosphorylation dependent
mechanism [18,19]. Recently, it was shown that in adipose tissue
GLUT4-mediated glucose uptake induces ChREBP, which
activates de novo lipogenesis [20]. HCMV infection has been
shown to induce the cleavage of SREBPs and also to maintain
constitutive lipid synthesis by overriding sterol feedback control
during infection [10,11]. However, the fundamental mechanisms
responsible for HCMV-induced activation of lipid synthesis
remain poorly understood.
Upon infection HCMV directly induces the interferon (IFN)-
inducible iron-sulfur (Fe-S) cluster-binding protein, viperin
[21,22,23], and we recently showed that the HCMV-encoded
vMIA protein binds viperin and translocates it to mitochondria
where it inhibits fatty acid b-oxidation [24]. This results in
reduced cellular ATP levels and disruption of the actin
cytoskeleton, previously shown to increase viral infectivity
[25,26,27,28]. Here we demonstrate that the induced viperin is
also responsible for the increases in AMPK activity, GLUT4 and
lipogenic enzyme transcription, and enhanced lipid synthesis
observed in HCMV-infected cells. The interaction of viperin, but
not a mutant lacking the Fe-S cluster binding motif, with the
mitochondrial trifunctional protein (TFP) that mediates fatty acid
b-oxidation [29,30] is critical for these effects. These data suggest
that viperin is the key molecule that regulates lipid metabolism
during HCMV infection.
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Results
HCMV infection-induced viperin mediates multiple
metabolic effects, culminating in enhanced lipogenesis
Viperin interaction with the mitochondrial trifunctional protein
(TFP) depletes cytoplasmic ATP [24]. ATP depletion generally
results in AMP accumulation, which leads to the activation of
AMPK [31,32,33], and AMPK has been shown to be important for
HCMV-mediated alterations in metabolism [9]. To test whether
viperin expression mediated by HCMV infection is required for
AMPK activation, immortalized human fibroblasts (HFtelo),
expressing either no shRNA (wild type), luciferase-specific (Luc)
shRNA (control), or two different viperin shRNAs (viperin
knockdown), were infected as previously described (Figure S1A)
[24]. The AMPK activity in control cells at 2 days post infection
(dpi) was increased by 3-fold over that in non-infected cells, while no
change was observed in cells expressing viperin-specific shRNAs
(Figure 1A). The addition of Compound C, a specific AMPK
inhibitor [34], suppressed the measured enhancement.
Activation of AMPK induces GLUT4 expression [9,35], and
HCMV infection has been shown to activate GLUT4 indepen-
dently of its normal control mechanisms, which include external
glucose concentration, ATP-citrate lyase (ACL) activation, insulin
stimulation, and Akt activity [8]. We asked whether viperin
expression affects GLUT4 expression and GLUT4-mediated
glucose uptake. HFTelo cells expressing no shRNA, control shRNA
or viperin shRNAs were infected with HCMV and GLUT4 mRNA
was measured by quantitative RT-PCR (Figure 1B). The mRNA
levels significantly increased in infected cells expressing no shRNA
or Luc shRNA, while no increase occurred in the viperin
knockdown cells at 1 dpi and increases at 3 dpi were minimal
(Figure 1B). These data indicate that viperin expression is required
for induction of GLUT4 during HCMV infection. Because GLUT4
expression should increase glucose import, we also measured the
levels of glycolysis in the infected control and viperin-specific
shRNA-expressing cells. Consistent with GLUT4-dependent glu-
cose accumulation, glycolysis was increased in control cells but not
viperin knockdown cells (Figure S1B).
ChREBP is a glucose-responsive transcription factor that
activates the transcription of lipogenic enzymes and is highly
regulated by GLUT4 in adipose tissue [20]. To determine if
ChREBP plays a role in HCMV infection, we measured the
mRNA levels of ChREBPa (the canonical isoform) and ChREBPb
(a novel isoform) [20] in control and viperin knockdown cells
(Figure 1C). Both transcripts of ChREBP were increased upon
HCMV infection, and in both cases the increase was significantly
blocked in cells expressing viperin shRNA (Figure 1C). This was
particularly evident at 3 dpi. ChREBP translocates from the
cytoplasm to the nucleus to function as a transcription factor, and
we examined the intracellular localization of ChREBP in HCMV-
infected cells. ChREBP was detected in both cytoplasm and
nucleus of control cells (over 50% of HCMV-infected cells) at
3 dpi, while in the viperin knockdown cells it was not present in
the nucleus (Figure 1D).
ChREBP translocation to the nucleus induces lipogenic enzyme
transcription, and HCMV infection is known to increase de novo
fatty acid synthesis by inducing expression of lipogenic enzymes
[10,11]. We therefore measured mRNA levels for the key
lipogenic enzymes ATP-citrate lyase (ACL), Acetyl-coenzyme A
(CoA) carboxylase (ACC) 2, fatty acid synthase (FAS), diacylgly-
cerol acyltransferase (DGAT) 1, and DGAT2. All of these
transcripts were increased upon HCMV infection of cells
expressing no shRNA or Luc shRNA, and in all cases the increase
was substantially blocked in cells expressing viperin-specific
shRNA (Figure 2A). This was particularly evident at 3 dpi.
Interestingly, SREBP1 cleavage was independent of viperin
expression during HCMV infection (Figure S2A), although
inhibition of SREBP1 cleavage has been shown to reduce lipid
synthesis and impair HCMV growth [10,11]. The results suggest
that in HCMV-infected fibroblasts, like in adipose tissue, GLUT4-
mediated glucose uptake and de novo lipogenesis are dominantly
regulated by ChREBP rather than SREBP1, and that this process
is viperin-dependent. To address this we measured lipogenesis in
cells expressing GLUT4- and ChREBP-specific shRNAs during
HCMV infection (Figure S2B and S2C). The mRNA levels of
ChREBP and lipogenic enzymes were substantially lower in
GLUT4 knockdown cells than control cells during HCMV
infection (Figure S2C). Like in control cells, GLUT4 mRNA
content was increased in ChREBP knockdown cells, while the
increases in lipogenic enzyme mRNA levels were substantially
blocked at 1 and 3 dpi (Figure S2C). The data support a
mechanism in which viperin induces GLUT4 expression, increas-
ing glucose uptake and thus ChREBP, which in turn activates de
novo lipogenesis during HCMV infection.
The increase in lipogenic enzyme levels upon HCMV
infection results in increased lipid synthesis and lipid droplet
(LD) induction [10,11]. We therefore measured total lipid
synthesis in the HCMV-infected cells using 14C-labeled acetate.
Total lipid synthesis in control cells at 2 dpi during a 3 hour
labeling period was increased by 2.5-fold over that in non-
infected cells, while no change was observed in the viperin
shRNA-expressing cells (Figure 2B). We also examined forma-
tion of LDs, which are storage compartments for triglycerides
and long chain fatty acids [36,37]. LDs increased in diameter by
approximately 3–4-fold in the HCMV-infected control cells at
3 dpi, while both the number and size of the induced LDs were
dramatically reduced in viperin shRNA expressing cells
(Figure 2C and D). No changes in LD number or size were
observed upon viperin knockdown without HCMV infection.
These data suggest that in the absence of viperin HCMV
consumes pre-existing lipids, reducing the size and number of
LDs, but cannot induce lipids to replenish them.
Author Summary
Virus infection induces the production of interferons,
which in turn stimulate the production of a set of proteins
that often have antiviral functions. One of these interferon-
inducible proteins is viperin, the product of the human
Rsad2 gene. Human cytomegalovirus (HCMV) paradoxically
induces expression of viperin independently of the
interferon response, and we previously showed that a
virus-encoded protein transports the induced viperin to
mitochondria where it interferes with fatty acid b-
oxidation, a major energy generating system of the cell.
We show here that this ultimately results in enhanced lipid
synthesis by the infected cell that is essential for
production of infectious virus. The mechanism involves
sensing the depletion in ATP levels caused by inhibition of
fatty acid b-oxidation by the enzyme AMP-induced protein
kinase. This induces a cascade of events that result in the
increased transcription of genes encoding lipogenic
enzymes and consequent lipid biogenesis that is needed
by the virus for adequate membrane envelope formation.
Thus HCMV uses the interferon-inducible protein viperin,
known to be antiviral for other viruses, even for HCMV
itself if viperin is pre-expressed in cells prior to infection, to
modulate the metabolic status of the cell to facilitate its
replication.
Viperin-Dependent Lipogenesis in HCMV Infection
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Having previously observed that HCMV-encoded vMIA is
responsible for targeting viperin to the mitochondria [24], we asked
whether vMIA expression affects viperin-dependent lipogenesis
during HCMV infection. MRC5 fibroblasts were infected with
RVHB5 (control wild type HCMV), or RVHB5DvMIA, a mutant
of this virus lacking vMIA, in the presence of ZVAD-FMK, a broad-
spectrum caspase inhibitor that prevents apoptosis otherwise
induced by HCMV lacking vMIA [38]. In contrast to the results
with cells infected by wild type virus, in RVHB5DvMIA-infected
cells viperin did not substantially co-localize with mitochondria at
1 dpi (Figure S2D) and lipogenesis was substantially blocked (Figure
S2E). These results indicate that viperin translocation to the
mitochondria by vMIA is required for the lipogenesis induced
during HCMV infection.
Viperin-dependent lipid synthesis is required for formation
of HCMV viral envelope and production of infectious virus
Enhanced lipid synthesis is thought to provide the membrane
necessary for proper HCMV envelope formation. To explore the
role of viperin in this process we analyzed the viral particles
Figure 1. Viperin expression is necessary for HCMV-induced metabolic effects. HFtelo cells stably expressing no shRNA, control luciferase
(Luc) shRNA or viperin shRNAs were infected with HCMV at an moi of 2 for the indicated days. (A) AMPK activity. Cells were treated with DMSO or the
AMPK inhibitor, Compound C (CompC; 5 mM). At 2 days post infection (dpi), the cells were harvested in lysis buffer and the lysates from 2.56104 cells
were assayed for AMPK activity. Data are presented as mean 6 SEM of duplicate samples and are representative of two individual experiments. *,
P,0.01. (B and C) mRNA levels of GLUT4 (B), ChREBPa and ChREBPb (C). Total RNA was isolated, and the mRNA levels were measured by quantitative
RT-PCR and normalized to b actin mRNA. Data are presented as means 6 SEM of triplicate samples and are representative of three individual
experiments. (D) Cells were stained with antibody specific to ChREBP and antibody to the HCMV protein IE-1 to identify infected cells. The filled
arrows indicate ChREBP localized to the nuclei, and the open arrows indicate ChREBP localized to cytoplasm. Fifty infected cells were examined for
ChREBP nuclear localization. ChREBP was detected at the nuclei in over 50% of HCMV-infected control cells and less than 1% of viperin knockdown
cells. Scale bar, 20 mm.
doi:10.1371/journal.ppat.1003497.g001
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Figure 2. Viperin expression induces HCMV-induced lipogenesis. HFtelo cells stably expressing no shRNA, control luciferase (Luc) shRNA or
viperin shRNAs were infected with HCMV at an moi of 2 for the indicated days. (A) Lipogenic enzyme mRNA levels. Total RNA was isolated, and the
mRNA levels were measured by quantitative RT-PCR and normalized to b actin mRNA. Data are presented as means 6 SEM of triplicate samples and
are representative of three individual experiments. ACL, ATP-citrate lyase; ACC2, acetyl-coenzyme A (CoA) carboxylase 2; FAS, fatty acid synthase;
DGAT1 and DGAT2, diacylglycerol acyltransferases 1 and 2. (B) Total lipid synthesis. The infected cells were labeled with [14C]-acetate for 3 hr. Total
lipids from 16105 cells were extracted and [14C] incorporation assessed. Data are presented as mean 6 SEM of triplicate samples and are
representative of two individual experiments. *, P,0.0001. (C) Cells were stained with antibodies specific to adipose differentiation-related protein
(ADRP), a marker for lipid droplets (LDs), and gB, an HCMV glycoprotein. The filled arrows indicate the accumulated LDs, and the open arrows indicate
barely detectable LDs in HCMV-infected viperin knockdown cells. Scale bar, 20 mm. (D) Quantification of LDs. LD diameter: mean of 500 LDs 6 SEM.;
LD number: mean of 50 cells 6 SEM *, P,0.0001.
doi:10.1371/journal.ppat.1003497.g002
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generated in the presence and absence of viperin by quantitating
cytoplasmic non-enveloped particles (capsids and tegumented
capsids) and enveloped particles (double-layered particles formed
by tegumentation and secondary envelopment in the secretory
pathway) in control and viperin knockdown cells by electron
microscopy, late in infection to allow accumulation of quantifiable
virions (Figure 3A). In normal cells or those expressing the control
shRNA approximately 65% of the cytoplasmic viral particles were
enveloped and this was reduced to approximately 25% in the
viperin shRNA expressing cells (Figure 3B). We also observed a
substantial decrease in the production of infectious extracellular
and intracellular virus in the cells expressing viperin shRNA
(Figure 3C). However, the viral genome copy numbers present in
both extracellular and intracellular particles produced from the
cells after infection were similar, regardless of shRNA expression
(Figure 3D). In addition, we observed no change in the expression
of the intracellular HCMV viral proteins MCP (a capsid protein),
gB (an envelope protein), and pp65 and pp28 (tegument proteins)
(Figure 3E). The data indicate that cells with impaired viperin
expression produce a similar number of viral particles but many of
them are non-infectious because of defective envelopment.
Targeting viperin to mitochondria leads to increased
lipogenesis
The reduction in cellular ATP levels and disruption of the actin
cytoskeleton induced by vMIA-mediated transfer of viperin to
mitochondria can be replicated in the absence of infection by
directly targeting viperin using a mitochondrial localization
sequence (MLS) [24]. The activity requires a functional Fe-S
cluster binding site [24]. To determine if this is also true for the
effects on lipogenesis, we used previously described chimeric
mouse viperin constructs: MLS-viperin, in which the N-terminal
amphipathic a-helix of viperin, responsible for its ER and LD
association [39,40], was replaced by the MLS of vMIA, and MLS-
viperin (DCA) in which two cysteine residues (88 and 91) required
for Fe-S cluster association were mutated to alanine [24]. We also
used a fusion construct with the enhanced green fluorescent
protein (EGFP) attached to MLS-viperin, and one with the MLS
linked to EGFP directly. Transfected cells were purified by
Streptavidin Microbeads using a biotinylated antibody to Thy1.1,
also encoded in the construct and separated by an IRES. We
examined the expression of GLUT4 and ChREBP (Figure 4A), the
intracellular localization of ChREBP (Figure S3A), the expression
of lipogenic enzymes (Figure 4B), the accumulation of LDs
(Figure 4C), and total lipid synthesis using 14C-labeled acetate as a
substrate (Figure 4D) in human viperin knockdown cells expressing
the chimeric proteins. Expression of the mouse constructs is not
affected by the human-specific shRNAs. In contrast to the cells
expressing a control vector or MLS-GFP, the cells expressing
MLS-viperin or MLS-viperin-GFP significantly increased
GLUT4, ChREBP and lipogenic gene expression, showed nuclear
localization of ChREBP, exhibited increased total lipid synthesis,
and accumulated LDs (Figure 4A–4D and S3A), indicating that
mitochondrial viperin directly induces GLUT4-mediated de novo
lipogenesis. Cells expressing wild type viperin, which does not
accumulate in mitochondria, or MLS-viperin (DCA) did not show
the increase in mRNA levels, nor did they increase total lipid
synthesis or accumulate LDs (Figure 4A–4D). This indicates that
the viperin effects on lipid metabolism require mitochondrial
localization and Fe-S cluster binding. Similar results were
observed in viperin knockdown cells expressing a chimeric viperin
protein with the N-terminal a-helix replaced by the MLS of
Tom70, a host cellular mitochondrial protein (Figure S3B). This
excludes the possibility that the MLS from vMIA was itself
responsible for the effect. To determine whether the de novo
lipogenesis observed was dependent on GLUT4-mediated glucose
uptake we measured lipogenic enzyme transcripts in cells
expressing the chimeric proteins in the presence or absence of
glucose in the medium (Figure 4E). In the absence of glucose the
cells expressing MLS-viperin-GFP had significantly increased
GLUT4 mRNA content, but mRNA levels for ChREBP and
the lipogenic enzymes were unchanged. We also examined
lipogenesis in GLUT4 and ChREBP knockdown cells expressing
the chimeric proteins (Figure S3C). The expression of ChREBP
and lipogenic enzymes in GLUT4 knockdown cells expressing
MLS-viperin-GFP was unaffected. However, GLUT4 expression
was induced in ChREBP knockdown cells expressing MLS-
viperin-GFP, while the expression of lipogenic enzymes was
unaffected (Figure S3C). The data support a mechanism in which
mitochondrial viperin enhances GLUT4 expression, increasing
glucose uptake and thus ChREBP activation, which in turn
activates de novo lipogenesis. Similar results were generated using
viperin knockout murine embryonic fibroblasts (MEFs) expressing
the chimeric proteins (Figure S4). In contrast to the cells expressing
a control vector or MLS-GFP, cells expressing MLS-viperin-GFP
exhibited significantly increased lipogenic gene expression (Figure
S4A), accumulated LDs (Figure S4B), and increased total lipid
synthesis (Figure S4C).
Viperin interaction with TFP is responsible for the
increased lipogenesis
Our previous work showed that viperin interaction with the
mitochondrial enzyme TFP inhibits fatty acid b-oxidation [24]. To
determine whether this interaction is responsible for the observed
effects on lipid metabolism, we measured lipogenesis in human
fibroblasts genetically deficient in the TFP b subunit (HADHB)
transiently expressing each chimeric protein. In contrast to the
results with wild type fibroblasts, lipogenesis in TFP-deficient
fibroblasts expressing either MLS-viperin-GFP or Tom70MLS-
viperin was unaffected (Figure 5 and S5). These results indicate
that the viperin interaction with TFP is required for the enhanced
lipid synthesis induced by HCMV infection, suggesting that
GLUT4 activation and lipogenic enzyme stimulation are likely
downstream of the inhibition of fatty acid b-oxidation. To address
this we examined lipogenesis in cells treated with etomoxir, an
inhibitor of mitochondrial long chain fatty acid oxidation
(Figure 6). As anticipated, increased expression of GLUT4,
ChREBP and lipogenic enzymes, as well as accumulation of
LDs, were all observed in the etomoxir-treated cells. Taken
together, the data indicate that the interaction of viperin with TFP
and consequent inhibition of fatty acid b-oxidation is required for
the induction of lipogenesis.
The effects of HCMV infection on lipogenesis depend on
the viperin-TFP interaction
Finally, to control for the specificity of the viperin shRNA effects
and confirm that viperin is involved in lipogenesis in the context of
viral infection, we infected cells with a recombinant HCMV
(HCMV.mVIP) in which the loci US7–US16, nonessential for in
vitro replication, were replaced by mouse viperin-GFP under an
inducible promoter such that expression could be enhanced by the
addition of doxycycline, although some breakthrough transcrip-
tion occurred in the absence of doxycycline [24]. Expression of
mouse viperin-GFP upon HCMV.mVIP infection restored the
wild type phenotype in human viperin knockdown cells in terms of
expression of GLUT4, ChREBP and lipogenic enzymes (Figure 7A
and B), accumulation of LDs (Figure 7C), formation of viral
Viperin-Dependent Lipogenesis in HCMV Infection
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Figure 3. Viperin-dependent lipid synthesis is required for formation of HCMV viral envelope and production of infectious virion.
(A) Transmission electron micrographs of HCMV-infected HFtelo cells stably expressing the indicated shRNAs. Monolayers were infected with HCMV
at an moi of 2 and processed for EM at 7 dpi. Multiple frames from each sample were imaged and photographed. Particles from a representative cell
are shown. White and black arrows indicate non-enveloped particles and enveloped particles, respectively. Nu, nucleus; Cyto, cytoplasm. Scale bar,
1 mm. (B) The numbers of enveloped and non-enveloped particles were counted in each frame and calculated as a ratio of enveloped particles to
total particles in the cytoplasm of infected cells. The graphs indicate the mean percent of the enveloped particles per total 20–50 particles in each
frame (from .10 cells of each sample) 6 SEM *, P,0.0001. (C) HFtelo cells expressing the indicated shRNAs were infected with HCMV at an moi of
0.2, and supernatants and cells were harvested at 6 dpi. Virus yield was quantified by a fluorescence-based virus infectivity assay. Data are presented
as means 6 SEM of duplicate samples and are representative of two individual experiments. *, P,0.01; **, P,0.005. (D) Viral genome copy numbers
in viral particles harvested from supernatants and cells at 6 dpi (initial moi of 2). The viral DNAs were extracted and assayed by real-time PCR. (E)
Expression of HCMV viral proteins, MCP, gB, pp65, and pp28 in HFtelo cells expressing the indicated shRNAs at 6 dpi (initial moi of 2). Each protein
was detected by immunoblot using specific monoclonal antibodies. Grp94 served as a protein-loading control.
doi:10.1371/journal.ppat.1003497.g003
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Figure 4. Targeting viperin to mitochondria leads to increased lipogenesis. The N-terminal 42 residue a-helical region of mouse viperin
(WT), a mouse viperin-GFP chimera, or viperin (DCA) was replaced by the mitochondrial localization sequence (MLS) of the HCMV protein vMIA. The
MLS was also directly fused to enhanced green fluorescent protein (EGFP) as a negative control (MLS-GFP). (A and B) mRNA levels of GLUT4 and
Viperin-Dependent Lipogenesis in HCMV Infection
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envelope (Figure S6), and production of infectious extracellular
and intracellular virus (Figure 7D).
Discussion
The effects of HCMV upon the metabolic status of infected cells
reflect a commitment to macromolecular synthesis, including lipid
biosynthesis, rather than generation of energy [4,5,6,7]. Intracellu-
lar ATP levels actually decrease, and this has been postulated to
induce disruption of the actin cytoskeleton that enhances viral
replication [25,26,27,28]. Lipogenesis is increased and LDs
accumulate, interpreted to reflect the requirement for viral envelope
[4,5,6,7,10,11]. We previously showed that the decrease in ATP
and cytoskeletal actin modulation is because viperin, induced by
HCMV and translocated to mitochondria by vMIA, interacts with
TFP and inhibits fatty acid b-oxidation [24]. We now show that
these events are also responsible for increased lipogenesis. When
viperin expression is prevented in HCMV-infected cells they do not
exhibit the alterations of lipid metabolism normally observed and,
although viral protein synthesis is unaffected and capsids are
generated, envelope formation is impaired and the production of
infectious virus is reduced. Furthermore, all of these features are
restored when mouse viperin is expressed from an HCMV
recombinant. In addition, infection by an HCMV mutant lacking
vMIA, and therefore unable to transfer viperin to mitochondria,
fails to induce lipogenesis. Targeting viperin to mitochondria
induces these metabolic changes directly, but not when the cells lack
functional TFP, and an activity of viperin mediated by Fe-S cluster
binding is essential.
The cumulative data suggests that viperin-mediated inhibition
of fatty acid b-oxidation reduces the generation of ATP and
activates AMPK, which results in the induction of GLUT4 to
increase glucose uptake. Activation of AMPK has been shown to
be important for HCMV-mediated alterations in metabolism [9].
The increase in cytosolic glucose, in addition to inducing
glycolysis, induces ChREBP, which, upon binding glucose,
accumulates in the nucleus and activates the transcription of
genes encoding lipogenic enzymes, enhancing lipid synthesis
during HCMV infection. Interestingly, in HCMV-infected cells
expressing viperin-specific shRNAs ChREBP translocation to the
nucleus was indeed inhibited, but it was polarized rather than
remaining diffuse and cytosolic (Fig. 1D). The localization is
reminiscent of the localization of the complex virus assembly
compartment that develops in HCMV-infected cells, but as
HCMV infection causes multiple effects on cellular morphology
the meaning of this observation is unclear. It is also conceivable
that the apparent redistribution of ChREBP may an artifact since
HCMV expresses an Fc receptor that localizes to the AC late in
infection and binds non-specifically to polyclonal rabbit antibod-
ies. This requires further analysis. Consistent with the role of
GLUT4-mediated glucose import in inducing ChREBP activity,
when viperin is targeted to mitochondria directly in cells cultured
without glucose, GLUT4 transcription is still induced but
ChREBP transcription is not; nor is the transcription of the
lipogenic enzymes that depend on ChREBP expression. We do
not know how rapidly these effects on metabolism begin after
HCMV infection. Most measurements have been performed at
day 1 post-infection or later. However, the kinetics of viperin and
vMIA expression are very similar, and viperin substantially co-
localizes with mitochondria after 24 hrs, so we might expect that
these effects are initiated quite rapidly during the infection.
Lipid synthesis is induced by HCMV infection, and in cells
lacking viperin expression this increased synthesis is not observed.
Presumably because of this the increase in size and number of LDs
induced by infection is also not seen in the viperin shRNA-
expressing cells. These findings are precisely replicated in the same
cells uninfected but expressing mitochondrially-targeted viperin.
HCMV infection in the absence of viperin induction both
eliminates the size increase and reduces the number of LDs,
suggesting that initiating viral envelope formation consumes pre-
existing lipids but without the viperin-mediated induction of
lipogenesis they are not replaced. This results in a significant
decrease in the production of infectious virus. Envelopment of
HCMV proceeds by a complex process, involving initial envelop-
ment in nuclear membrane that is shed in the cytoplasm.
Secondary envelopment occurs by budding into the secretory
pathway. Electron microscopy clearly showed that the number of
enveloped particles formed in the secretory pathway was
substantially reduced in the viperin knock down cells. However,
the synthesis of viral proteins and the total number of viral
particles, assessed by genome copy number was unaffected.
Although HCMV-induced cleavage of SREBP1 is independent
of viperin expression, HCMV infection does not induce expression
of lipogenic enzymes and lipid synthesis in the absence of viperin.
There are two genes encoding SREBPs, SREBP1 and SREBP2,
and SREBP1 exists in two forms, a and c, depending on the use of
alternate promoters. This renders a simple interpretation difficult,
but mice lacking SREBP1c do exhibit a reduction of some, but not
all lipogenic enzyme transcripts in the liver [41]. Hepatic mRNA
expression levels of lipogenic genes were also decreased in
ChREBP knockout mice, resulting in a 65% reduction of fatty
acid synthesis rates, despite normal mRNA levels of SREBP1c and
cleavage of SREBP1 protein [12]. In the case of HCMV infection
SREBP1 cleavage may be insufficient to substantially activate
lipogenesis in the absence of ChREBP induction, even though
preventing SREBP1 cleavage using an shRNA specific for the
enzyme SCAP (SREBP-cleavage activating protein) inhibited lipid
synthesis and HCMV growth [10,11]. SREB1a also activates
genes controlling cholesterol biosynthesis, which may be why
inhibiting SREBP cleavage also affects HCMV replication. Thus
there may be synergy between SREBP1 and ChREBP in ensuring
efficient membrane generation. Nevertheless, the viperin-depen-
dent induction of lipogenesis by ChREBP is clearly essential for a
successful HCMV infection.
ChREBPs (A) and lipogenic enzymes (B) in viperin knockdown HFtelo cells transiently expressing the indicated chimeric viperin proteins. The mRNA
level in the cells expressing a control vector was set at 1. Data are represented as means 6 SEM of triplicate samples and are representative of two
individual experiments. *, P,0.01; **, P,0.05; ***, P,0.005. (C) LDs were monitored in viperin knockdown HFtelo cells transiently expressing the
indicated chimeric viperin proteins. Cells were stained with ADRP and viperin antibodies. The filled arrows indicate the accumulated LDs in the
transfected cells. The open arrows indicate the small basal LDs in the non-transfected or transfected cells. Scale bar, 20 mm. (D) Total lipid synthesis.
Viperin knockdown HFtelo cells transiently expressing the indicated chimeric viperin proteins were labeled with [14C]-acetate for 3 hr. Total lipids
from 56104 cells were extracted in chloroform-methanol and [14C] incorporation assessed. Data are presented as mean 6 SEM of triplicate samples
and are representative of two individual experiments. *, P,0.001. (E) The viperin knockdown HFtelo cells were transfected with the indicated
constructs. At 1 day after transfection, the cells were transferred to serum-free medium in the presence and absence of glucose and incubated for
24 hr at 37uC. GLUT4, ChREBPs and lipogenic enzyme mRNA levels were measured. Data are represented as means 6 SEM of triplicate samples and
are representative of two individual experiments. *, P,0.005; **, P,0.05.
doi:10.1371/journal.ppat.1003497.g004
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Overall, the data indicate that viperin is the key regulator of
HCMV-induced modulation of lipid metabolism, and it may
present a novel target for HCMV therapy. We are still left, however,
with the vexed question of the normal function of viperin. Are there
physiological circumstances in which a modification of lipogenesis
mediated by viperin would be important, and if that is so, how does
the molecule enter mitochondria to mediate this effect? Does this
play a role in any of the inhibitory effects on other viruses that have
been attributed to viperin? The answers to these questions await
further experiments.
Figure 5. Viperin interaction with TFP is responsible for increased lipogenesis. (A) mRNA levels of GLUT4, ChREBPs and lipogenic enzymes
in TFP b subunit deficient (HADHB (2)) cells transiently expressing the indicated chimeric viperin proteins were measured as described above. Data
are represented as means 6 SEM of triplicate samples and are representative of two individual experiments. *, P,0.05. (B) LDs were monitored in
HADHB (2) cells transiently expressing the indicated chimeric viperin proteins as described above. The arrows indicate the small basal LDs in the non-
transfected or transfected cells. Scale bar, 20 mm.
doi:10.1371/journal.ppat.1003497.g005
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Materials and Methods
Cells, viruses, antibodies, and reagents
Human foreskin fibroblast (HFF) cells were purchased from
Yale Skin Diseases Research Center Core. Telomerase-immortal-
ized human fibroflast (HFtelo) cells were kindly provided by Dr. T.
Shenk (Princeton University). Trifunctional protein (TFP) b
subunit (HADHB) deficient fibroblasts (GM20265 and
GM20266) were obtained from the Coriell Institute. MRC5
fibroblasts were kindly provided by Dr. E.S. Mocarski (Emory
University). Murine embryonic fibroblasts (MEFs) used in the
study were isolated from viperin (Rsad2) knockout C57BL/6 mice
[24,42] and immortalized by serial passages as described
previously [43].
HCMV strain AD169 was kindly provided by Dr. W.J. Britt
(University of Alabama at Birmingham). HCMV strain RVHB5
and HCMV mutant RVHB5DvMIA were provided by Dr. E.S.
Mocarski (Emory University) [38]. Recombinant HCMV.mVIP
used in the study was previously constructed utilizing a recombi-
nation strategy to insert Tet-on inducible mouse viperin-GFP
fusion plasmid into the HCMV genome maintained in a bacterial
artificial chromosome (BAC) [24].
HCMV-encoded proteins were detected with monoclonal anti-
bodies (mAb). mAbs to MCP (UL86) (28-4), pp65 (UL83) (28-19),
pp28 (UL99) (41-18), gB (UL55) (27-78) and IE-1 (UL123) (P63-27)
were gifts from Dr. W.J. Britt (University of Alabama at
Birmingham). mAb to viperin (aa 263-277) (MaP.VIP) was described
previously [44,45]. mAbs to adipose differentiation-related protein
Figure 6. Inhibition of fatty acid b-oxidation induces lipogenesis. (A and B) mRNA levels of GLUT4 and lipogenic enzymes (A) and ChREBPs
(B) in HFtelo cells treated with etomoxir (0.2 mM), an inhibitor of mitochondrial long chain fatty acid oxidation, for 3 or 24 hr. Data are represented as
means6 SEM of triplicate samples and are representative of two individual experiments. *, P,0.005; **, P,0.05. (C) LDs were monitored in etomoxir-
treated HFtelo cells. Cells were stained with ADRP and viperin antibodies. Scale bar, 20 mm.
doi:10.1371/journal.ppat.1003497.g006
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Figure 7. Specificity of the viperin effects on modulation of lipid metabolism in HCMV infection. (A–C) HFtelo cells stably expressing the
indicated shRNAs were infected with recombinant HCMV.mVIP, in which the loci US7–US16 were replaced by doxycycline (Dox)-inducible mouse
viperin-GFP, at an moi of 2 for 1 or 3 days. Dox (2 mg/ml) was added before infection. mRNA levels of GLUT4 and ChREBPs (A) and lipogenic enzymes
(B) were measured. Data are presented as means6 SEM of triplicate samples and are representative of two individual experiments. Cells were stained
with antibody specific to ADRP (C). The HCMV.mVIP-infected cells were detected by expression of viperin-GFP. The arrows indicate the accumulated
LDs. Scale bar, 20 mm. (D) HFtelo cells expressing the indicated shRNAs were infected with HCMV.mVIP at an moi of 0.2, and supernatants and cells
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(ADRP) (Progen), SREBP1 (IgG-2A4, BD Pharmingen) and GRP
94 (Research Diagnostics) were used. Polyclonal rabbit Abs to
ChREBP (Abcam) and actin (Santa Cruz Biotech) were also used.
Goat anti-rabbit and anti-mouse Ig secondary Abs were purchased
from Molecular Probes.
Caspase inhibitor I, ZVAD (OMe)-FMK (Calbiochem) and
AMPK inhibitor, Compound C (Sigma) were used.
AMPK activity assay
HFtelo cells stably expressing the indicated shRNAs were
plated in duplicate and serum starved for 24 hr. Cells were
infected with HCMV at a multiplicity of infection (moi) of 2. The
cells were treated with DMSO or the AMPK inhibitor,
Compound C (5 mM). At 2 dpi, the cells were harvested in lysis
buffer (50 mM Tris-HCl, pH 7.4, 1% Triton X-100, 1 mM
EGTA, protease inhibitor cocktail (+EDTA) (Roche), Phospha-
tase inhibitor cocktail (Roche) and 1 mM DTT). The cell lysates
were assayed for AMPK activity using CycLex AMPK Kinase
Assay Kit (MBL International Corporation). Absorbance of each
sample was measured at wavelength of 450 nm using a Victor2
fluorometer (PerkinElmer).
shRNA knockdown of viperin, GLUT4 and ChREBP
Previously generated HFtelo cells stably expressing two distinct
short hairpin target sequences to viperin (Viperin shRNA1 and 2)
and a negative control, a target sequence to luciferase (Luc
shRNA) were used [24].
pGIPZ lentiviral plasmids with the short hairpin target sequences
to GLUT4 and ChREBP were used (Open Biosystems). To increase
knockdown efficiency, two lentiviral plasmids including different
target sequences were combined: GLUT4 shRNA1 (clone ID:
V3LHS_376729 and V3LHS_376733), GLUT4 shRNA2 (clone
ID: V3LHS_376728 and V3LHS_376730), ChREBP shRNA1
(clone ID: V3LHS_334248 and V3LHS_334249) and ChREBP
shRNA2 (clone ID: V3LHS_334249 and V3LHS_313472). HFtelo
cells stably expressing the indicated shRNAs were generated as
described previously [24]. Knockdown efficiency was assessed by
western blot or RT-PCR analysis.
Measurement of lipid synthesis
Lipid synthesis was measured as described [11,46]. Briefly,
HFtelo cells stably expressing the indicated shRNAs were plated in
triplicate and serum starved for 24 hr. The cells were infected with
HCMV at a multiplicity of infection (moi) of 2. At 2 hpi, cells were
washed, re-fed with fresh serum-free DMEM, and incubated at
37uC for 2 days. For transient expression assays, viperin knockout
MEFs were transfected with plasmids encoding chimeric proteins.
At 1 day after transfection, the cells were washed, re-fed with fresh
serum-free DMEM, and incubated at 37uC for 24 hr. The cells
were then counted and incubated in fresh serum-free DMEM
containing [1,2-14C] acetate (2 mCi/ml) and incubated at 37uC for
3 hr. Labeled cells were washed three times with ice-cold PBS and
lysed in 0.3 ml of Triton X-100 (0.5% in H2O). Lipids were
extracted by sequentially adding 0.75 ml of methanol, 0.75 ml of
chloroform, 0.75 ml of chloroform, and 0.75 ml of H2O, with
vortexing. Samples were centrifuged at 4,000 rpm for 15 min;
1.2 ml of organic phase (lower phase) was recovered and counted
in a scintillation counter.
Plasmids and transfections
The mouse wild type viperin cDNA construct of was generated
by PCR amplification and then cloned into pMXs-IRES-Thy1.1.
Chimeric viperin constructs were also generated in which residues
1–42 of WT viperin, WT viperin-GFP or mutant viperin (DCA,
substitution of cysteine residues 88 and 91 to alanine residues)
were replaced by the residues 1–34 (mitochondrial localization
sequence, MLS) of vMIA and then cloned into pMXs-IRES-
Thy1.1 to yield MLS-viperin, MLS-viperin-GFP or MLS-viperin
(DCA), respectively. For the chimeric viperin construct Tom70-
MLS-viperin, residues 1–42 of WT viperin were replaced by the
MLS (residues 35–68) of human Tom70 and cloned into pMXs-
IRES-Thy1.1. EGFP was also fused to residues 1–34 of vMIA
(MLS-GFP) or residues 35–68 of Tom70 (Tom70-MLS-GFP).
Plasmids were electroporated into viperin, GLUT4 and ChREBP
knockdown HFtelo cells and TFP b subunit (HADHB) deficient
HFF cells using a Nucleofector kit (Lonza). At 24 hr after
transfection, the transfected cells were sorted by Streptavidin
Microbeads (MACS Miltenyi Biotec) according to the manufac-
turer’s instructions. The sorted cells were used for quantitative
RT-PCR to measure the mRNA levels of lipogenic enzymes.
Immunofluorescence
Lipid droplets (LDs) were monitored by immunofluorescence.
The HCMV-infected or transfected fibroblasts were grown in 24-
well tissue culture plates containing a 13-mm-diameter coverslip.
The coverslips were harvested by first washing the cells with PBS
and then fixing the cells for 45 min at room temperature in 3%
paraformaldehyde freshly prepared in PBS. The coverslips were
washed in PBS and permeabilized with 0.5% saponin in PBS for
10 min. The coverslips were then blocked with 0.2% Tween in
PBS containing 10% normal goat serum for 20 min at room
temperature, followed by the addition of the anti ADRP mAb, and
incubated for 1 hr at room temperature. Following washing with
0.2% Tween in PBS, the coverslips were incubated with goat anti-
mouse Ig secondary Ab conjugated to dye diluted in 0.2% Tween
in PBS containing 2.5% normal goat serum for 1 hr at room
temperature. The coverslips were washed three times, rinsed once
in PBS and mounted with ProLong Gold Antifade reagent
(Molecular Probes). The images were acquired with a Leica TCS
SP2 confocal microscope.
Electron microscopy
HFtelo cells stably expressing the indicated shRNAs were
infected with HCMV or recombinant HCMV.mVIP at an moi of
2 and examined by electron microscopy at 7 dpi as described
previously [45,47]. Briefly, the cells were fixed with 2.5%
glutaraldehyde and post-fixed with 1% osmium tetroxide. Cells
were en bloc stained with 2% uranyl acetate, dehydrated,
infiltrated, and embedded in Epon. Sixty nanometer sections
were stained with lead citrate and examined using a Tecnai 12
Biotwin electron microscope.
Immunoblot analysis
Cleavage of SREBP1 was assayed by immunoblot as described
[10]. Cells were washed with PBS and solubilized in disruption
buffer (50 mM Tris (pH 7.4), 2% SDS, 5% 2-mercaptoethanol,
2.75% sucrose) containing proteinase inhibitors. The extracts were
boiled for 5 min, and centrifuged at 14,000 g for 3 min.
were harvested at 6 dpi. Dox (2 mg/ml) was added on day 0 and 3. Virus yield was quantified by a fluorescence-based virus infectivity assay. Data are
presented as means 6 SEM of duplicate samples and are representative of two individual experiments.
doi:10.1371/journal.ppat.1003497.g007
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Supernatants were collected and boiled in reducing sample
buffer. The supernatants were separated on 8% SDS-PAGE gels
and transferred to PVDF membranes (Millipore). The immuno-
blots were blocked in 5% skim milk, 0.05% Tween in PBS and
incubated with mAb against SREBP1, probed with anti-mouse
Ig horseradish-conjugated secondary antibody, followed by
incubation with enhanced chemiluminescence (ECL) reagents
(Pierce).
HCMV proteins were detected by immunoblotting. Cell pellets
were lysed in 1% Triton X-100 in TBS containing proteinase
inhibitors. Supernatants of lysates were collected and mixed with
reducing sample buffer. The supernatants were separated on 8%
or 10% SDS-PAGE gels. The immunoblots were probed with the
indicated antibodies as described above.
RNA extraction, cDNA preparation, and quantitative real-
time PCR
Cells were collected and total RNA extracted using the RNeasy
Mini kit (Qiagen). cDNA synthesis was performed with 1–2 mg RNA
using AffinityScript Multi Temperature cDNA synthesis kit accord-
ing to the manufacturer’s instructions (Stratagen). The cDNA
obtained from cells was quantified by real-time quantitative PCR (Q-
PCR) using SYBR Green (Applied Biosystems) on Stratagene
Mx3000P QPCR system. The following primers were used; b actin,
GCTCCGGCATGTGCAA (Fwd) and AGGATCTTCATGAGG-
TAGT (Rev); GLUT4, GGAGCTGGTGTGGTCAACACA (Fwd)
and GGAGCAGAGCCACAGTCATCA (Rev); ACL, TGTAA-
CAGAGCCAGGAACCC (Fwd) and CTGTACCCCAGTGGC-
TGTTT (Rev); ACC2, GACCACAGGTGAAGCTGAGA (Fwd)
and GTGTTCCCGTCCCCTCTTC (Rev); FAS, AGGCTGA-
GACGGAGGCCATA (Fwd) and AAAGCTCAGCTCCTGG-
CGGT (Rev); DGAT1, TCGCCTGCAGGATTCTTTAT (Fwd)
and GCATCACCACACACCAGTTC (Rev); DGAT2, TCA-
CCTGGCTCAATAGGTCCA (Fwd) and CCAGCAATCAGTG-
CAGAATATG (Rev); ChREBPa, AGTGCTTGAGCCTGGCC-
TAC (Fwd) and TTGTTCAGGCGGATCTTGTC (Rev);
ChREBPb, AGCGGATTCCAGGTGAGG (Fwd) and TTGTT-
CAGGCGGATCTTGTC (Rev). The Q-PCR was performed in
triplicate for each sample. Quantitation was performed by the
comparative Ct (2–[delta][delta]Ct) method. The Ct value for each
sample was normalized by the value for b actin gene. Three
independent experiments were analyzed statistically for differences
in the mean values, and P values are indicated in the figures.
The viral genome copy number was also quantified by real-time
PCR as described previously [47,48]. Viral DNA were isolated by
QIAamp DNA blood kit (Qiagen). The following primers, which
amplify a segment of the HCMV UL55 gene were used;
ACGTGAAGGAATCGCCAGGA (Fwd) and AGTTCCAG-
TACCCTGAAGTC (Rev).
Virus replication assay
HFFs or HFtelo cells stably expressing the indicated shRNA
were infected with HCMV or recombinant HCMV
(HCMV.mVIP) at an moi of 0.2 for 2 hr, washed, and cultured
in normal medium or medium supplemented with doxycycline.
Supernatants and cells were harvested at 6 dpi, and virus yield
was measured by a fluorescence-based virus infectivity assay
[49].
Statistical analyses
Results from all studies were compared with unpaired two-tailed
Student’s t test using GraphPad Prism 4 software. P values less
than 0.05 were considered significant.
Supporting Information
Figure S1 Viperin expression is necessary for HCMV-induced
modulation of metabolism. HFtelo cells stably expressing no
shRNA, control luciferase (Luc) shRNA or viperin shRNAs were
infected with HCMV at an moi of 2 for the indicated days. (A)
Viperin knockdown efficiency was analyzed by immunoblot using
anti-viperin antibody (MaP.VIP). Grp94 served as a protein
loading control. (B) Glycolysis. At 1 dpi, the cells were transferred
to glucose and glutamine-free medium, incubated at 37u for 1 hr
and glycolysis assessed by measuring the extracellular acidification
rate (ECAR), using an XF Extracellular Flux Analyzer (Seahorse
Bioscience). Data are presented as mean 6 SEM of duplicate
samples and are representative of two individual experiments.
(TIF)
Figure S2 Mitochondrial viperin induces de novo GLUT4 and
ChREBP-mediated lipogenesis during HCMV infection. (A)
Whole cell extracts were prepared from the infected cells. SREBP1
was detected by immunoblot using a specific antibody (IgG-2A4).
Actin served as a protein-loading control. SREBP1-P, SREBP1
precursor; SREBP1-M, cleaved mature form of SREBP1. (B)
HFtelo cells stably expressing two distinct GLUT4 shRNAs or
ChREBP shRNAs were infected with HCMV at m.o.i. of 2 for 3
day. The knockdown efficiency was analyzed by RT-PCR. Actin
served as a loading control. (C) GLUT4, ChREBP and lipogenic
enzyme mRNA levels in HFtelo cells expressing luciferase (Luc),
GLUT4 or ChREBP shRNAs after HCMV infection at an moi of
2 for 1 or 3 days. Total RNA was isolated, and the mRNA levels
were measured by quantitative RT-PCR and normalized to b
actin mRNA. Data are presented as means 6 SEM of triplicate
samples and are representative of two individual experiments.
GLUT4, glucose transporter 4; FAS, fatty acid synthase; DGAT1,
diacylglycerol acyltransferases 1. (D) MRC5 fibroblasts were
infected with wild type RVHB5 strain of HCMV (HCMV) or
mutant RVHB5 lacking vMIA (DvMIA-HCMV) at m.o.i. of 2 for
1 day in the presence of the caspase inhibitor ZVAD-FMK
(50 mM). Cells were stained with anti-viperin (MaP.VIP) and anti-
calnexin (ER marker) antibodies, antibodies to the HCMV protein
pp65 to identify infected cells, and Mitotracker Red to visualize
mitochondria. Scale bar, 10 mm. (E) MRC5 fibroblasts were
infected with HCMV or DvMIA-HCMV at m.o.i. of 2 for 1 or 3
days in the absence and presence of ZVAD-FMCK5 (50 mM).
Total RNA was isolated, and the mRNA levels were measured by
quantitative RT-PCR and normalized to b actin mRNA. Data are
presented as means 6 SEM of triplicate samples and are
representative of two individual experiments.
(TIF)
Figure S3 Targeting viperin to mitochondria induces de novo
lipogenesis. (A) The N-terminal 42 residue a-helical region of the
mouse viperin-GFP chimera was replaced by the MLS of the
HCMV protein vMIA. The MLS was also directly fused to
enhanced green fluorescent protein (EGFP) as a negative control
(MLS-GFP). ChREBP localization in viperin knockdown HFtelo
cells transiently expressing the indicated chimeric viperin proteins.
Cells were stained with antibody specific to ChREBP. The filled
arrows indicate ChREBP localized in the nucleus, and the open
arrows indicate ChREBP localized in the cytoplasm. Scale bar,
20 mm. (B) The N-terminal 42 residue a-helical region of mouse
viperin was replaced by the mitochondrial localization sequence
(MLS) of Tom70, a host cellular mitochondrial protein. mRNA
levels of lipogenic enzymes in viperin knockdown HFtelo cells
transiently expressing the indicated chimeric viperin proteins.
Data are represented as means 6 SEM of triplicate samples and
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are representative of two individual experiments. *, P,0.05. (C)
mRNA levels of GLUT4, ChREBP and lipogenic enzymes in
GLUT4 or ChREBP knockdown HFtelo cells transiently express-
ing the indicated chimeric viperin proteins. The mRNA level in
the cells expressing a control vector was set at 1. Data are
represented as means 6 SEM of triplicate samples and are
representative of two individual experiments. *, P,0.05.
(TIF)
Figure S4 Targeting viperin to mitochondria leads to increased
lipogenesis in viperin knockout MEFs. The N-terminal 42 residue
a-helical region of mouse viperin (WT), a mouse viperin-GFP
chimera, or viperin (DCA) was replaced by the mitochondrial
localization sequence (MLS) of the HCMV protein vMIA. The
MLS was also directly fused to enhanced green fluorescent protein
(EGFP) as a negative control (MLS-GFP). (A) mRNA levels of
lipogenic enzymes in viperin knockout MEFs (MEF-Viperin KO)
transiently expressing the indicated chimeric viperin proteins. The
mRNA level in the cells expressing a control vector was set at 1.
Data are represented as means 6 SEM of triplicate samples and
are representative of two individual experiments. *, P,0.005. (B)
LDs were monitored in viperin knockout MEFs transiently
expressing the indicated chimeric viperin proteins. Cells were
stained co-stained with ADRP and viperin antibodies. The filled
arrows indicate the accumulated LDs in the transfected cells. The
open arrows indicate the small basal LDs in the non-transfected or
transfected cells. Scale bar, 20 mm. (C) Total lipid synthesis.
Viperin knockout MEFs transiently expressing the indicated
chimeric viperin proteins were labeled with [14C]-acetate for
3 hr. Total lipids from 56104 cells were extracted and [14C]
incorporation assessed. Data are presented as mean 6 SEM of
triplicate samples and are representative of two individual
experiments. *, P,0.001.
(TIF)
Figure S5 Viperin interaction with TFP is responsible for
increased lipogenic enzyme gene expression. mRNA levels of
lipogenic enzymes in TFP b subunit deficient (HADHB (2)) cells
transiently expressing the indicated chimeric viperin proteins were
measured as described above. Data are represented as means 6
SEM of triplicate samples and are representative of two individual
experiments. *, P,0.05.
(TIF)
Figure S6 Specificity of the viperin effects on formation of
HCMV viral envelope. Transmission electron micrographs of
recombinant HCMV.mVIP-infected HFtelo cells stably expressing
the indicated shRNAs. Monolayers were infected with recombi-
nant HCMV.mVIP at an moi of 2 and processed for EM at 7 dpi.
Dox (2 mg/ml) was added on day 0 and 3. Multiple frames from
each sample were imaged and photographed. Particles from a
representative cell are shown. White and black arrows indicate
non-enveloped particles and enveloped particles, respectively.
Cyto, cytoplasm. Scale bar, 1 mm. The numbers of enveloped and
non-enveloped particles were counted in each frame and
calculated as a ratio of enveloped particles to total particles in
the cytoplasm of infected cells. The graphs indicate the mean
percent of the enveloped particles per total 10–30 particles in each
frame (from .10 cells of each sample) 6 SEM.
(TIF)
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